跳至主要内容
临床试验/JPRN-UMIN000023045
JPRN-UMIN000023045已完成未知

The effect of landiolol hydrochloride for primary lung cancer patients with tachyarrhythmia in the perioperative period - The effect of landiolol hydrochloride for primary lung cancer patients with tachyarrhythmia in the perioperative period

Department of Thoracic Surgery, Kitasato University0 个研究点目标入组 50 人开始时间: 2016年7月6日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
70years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • Patient corresponding to the contraindication of landiolol hydrochloride 1) Patients with cardiogenic shock 2) Patients with diabetic ketoacidosis or metabolic acidosis 3) Patients with auriculoventricular block(out of 2nd degree) or bradyarrhythmia including sick sinus syndrome 4)Patients with right cardiac failure from pulmonary hypertension 5) Patients with congestive cardiac failure 6) Patients with untreated phaeochromocytoma 7) Patients with a previous history of hypersensitivity to components of landiolol hydrochloride 8) Patients with bronchial asthma 9) Patient with sick sinus syndrome(Including a pacemaker implantation) 10) Patient who is pregnant woman also possibility of pregnancy or nursing mother 11) Patient who is judged as inappropriate by doctor in attendance

研究者

发起方
Department of Thoracic Surgery, Kitasato University

相似试验